Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$1.6MFederal grants as PI5 awards
1Patents grantedLatest Feb 3, 2026
73Papers3,340 citations
Federal awards and patents by year
AwardsPatents
5 awards · $1.6M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 23, 2019 | NIH | SBIR Phase I Immunoactivating Peptide AXT201 in Combination with Anti-PD-1 Antibody for Triple-Negative Breast Cancer | $300K | Asclepix Therapeutics, Inc. |
| Sep 3, 2018 | NIH | SBIR Phase II IND-enabling development of a biomimetic peptide drug for macular edema | $107K | Asclepix Therapeutics, Inc. |
| Aug 9, 2018 | NIH | SBIR Phase II IND-enabling development of a biomimetic peptide drug for macular edema | $824K | Asclepix Therapeutics, Inc. |
| Sep 1, 2015 | NIH | SBIR Phase I Development of a mimetic multimodal peptide for the treatment of macular edema | $278K | Asclepix Therapeutics, Inc. |
| Jun 8, 2015 | NIH | SBIR Phase I Long-term anti-angiogenic activity of intravitreal ellipsoid particles for NVAMD | $71K | Asclepix Therapeutics, Inc. |
2 patents as inventor
- US 12540171Asclepix Therapeutics, Inc.Feb 3, 2026
- US Asclepix Therapeutics, Inc.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#1,310
Awards as PI#417
Patents#155
Companies
- Asclepix Therapeutics, Inc.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.